Clomigen Citrate 50mg Calvin Scott

£76.00

Clomigen Citrate 50mg is a pharmaceutical-grade selective estrogen receptor modulator developed by Calvin Scott for comprehensive post-cycle therapy research protocols in controlled laboratory environments.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Clomigen Citrate 50mg Calvin Scott
Clomigen Citrate 50mg Calvin Scott
£76.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Research Overview: Clomigen Citrate 50mg

Clomigen Citrate 50mg is a selective estrogen receptor modulator (SERM) manufactured by Calvin Scott for advanced laboratory research applications. This pharmaceutical-grade compound demonstrates selective antagonistic and agonistic properties across different tissue types, making it invaluable for post-cycle therapy investigations. Researchers examining hormonal recovery mechanisms frequently utilise this compound to investigate endogenous testosterone restoration pathways and hypothalamic-pituitary-gonadal axis functionality. The compound’s molecular structure enables researchers to study estrogen receptor binding affinity variations across different tissue systems. Our Stroid UK Shop maintains stringent quality standards ensuring consistent research outcomes.

Laboratory Applications

Research scientists investigate Clomigen Citrate’s mechanism of action in blocking estrogen receptors within hypothalamic tissue while simultaneously activating estrogen receptors in hepatic tissue. Studies examine how this selective modulation influences luteinising hormone and follicle-stimulating hormone secretion patterns. Comparative research with compounds available through our post cycle therapy category demonstrates varying efficacy profiles across different SERM classifications. Researchers analyse dose-response relationships and temporal kinetics when examining hormonal recovery protocols. Advanced studies investigate potential synergistic effects when combined with other research compounds from our SARMs and peptides collections for comprehensive research methodologies.

Technical Specifications

Clomigen Citrate 50mg Product Specifications
Parameter Specification
Active Compound Clomifene Citrate
Concentration 50mg per tablet
Quantity 100 tablets
Manufacturer Calvin Scott
CAS Number 50-41-9
Molecular Formula C₂₆H₂₈ClNO·C₆H₈O₇
Molecular Weight 598.09 g/mol
Storage Cool, dry conditions

Research Compliance

This product is manufactured exclusively for in-vitro research purposes and is not intended for human consumption, therapeutic use, or any diagnostic applications. Researchers must possess appropriate laboratory facilities and qualifications before conducting studies with this compound.

Related